← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
NDA · New Drug Application · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-05-15
Drug application
- FDA Application #
NDA022344- Application type
- New Drug Application
- Brand name
- LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- AUROBINDO PHARMA LTD
- First approval
- 2018-05-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown